PharmX Technologies and Sigma Healthcare Forge Strategic Alliance

PharmX Technologies Limited (PHXTF) announced a significant strategic alliance with Sigma Healthcare on February 22, 2026. This collaboration is viewed as a pivotal moment in PharmX’s history, with the aim of strengthening the partnership between the two companies and mitigating risks inherent in their operations.

During an investor briefing, Philip England, Chairman of PharmX, emphasized the importance of this alliance. He highlighted that Sigma Healthcare, following its merger with Chemist Warehouse, has become an ASX 20 company with annual revenues exceeding $7 billion. Sigma Healthcare is currently PharmX’s largest customer, making the relationship crucial for both parties involved.

PharmX, while significantly smaller than Sigma, plays a vital role in supplying critical infrastructure for the pharmacy industry. Over the past year, both companies have recognized the potential risks within their partnership. As a result, they have been collaborating on a strategy to de-risk their relationship and ensure mutual stability.

Following Philip England’s introductory remarks, Tom Culver, the Chief Executive Officer of PharmX, provided insights into the transactional arrangements of the alliance. The objective is to create a framework that not only protects each company but also leverages their strengths for mutual benefit.

The upcoming interim results, set to be released on Wednesday, will provide further context regarding this strategic move. Both England and Culver expressed optimism about the future, believing that this partnership will position PharmX for sustainable growth and innovation in the pharmacy sector.

As the briefing concluded, the executives opened the floor for questions, inviting investors to engage with the details of this landmark collaboration. This alliance is poised to enhance PharmX’s strategic position in the market while ensuring that both companies can navigate future challenges effectively.

The formation of this strategic alliance marks a significant chapter for PharmX Technologies as it seeks to expand its influence and secure its role within an evolving industry landscape.